Stay updated on Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.
Latest updates to the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.2; no substantive changes to study details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check13 days agoChange DetectedPublication notes were updated to indicate PubMed entries are auto-filled and the revision tag updated to v3.3.1 (removing the older wording tied to v3.2.0).SummaryDifference0.1%
- Check21 days agoChange DetectedRemoved the government funding operating status notice from the page, which previously warned about updates due to funding lapses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check35 days agoChange DetectedNo additions or deletions were observed between the two screenshots. The page content appears unchanged.SummaryDifference0.3%
- Check64 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
- Check71 days agoChange Detected- Page version updates to v3.1.0. - Several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) are removed, indicating a narrowing of scope or rebranding rather than the addition of new topics.SummaryDifference0.3%
Stay in the know with updates to Emricasan for Decompensated NASH Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan for Decompensated NASH Cirrhosis Clinical Trial page.